Non-small cell bronchial carcinoma: optimisation of radiotherapy

被引:0
|
作者
Belliere, A [1 ]
Girard, N [1 ]
Chapet, O [1 ]
Ardiet, JM [1 ]
Mornex, F [1 ]
机构
[1] Ctr Hosp Lyon Sud, F-69495 Pierre Benite, France
关键词
radiotherapy; non-small cell bronchial carcinoma; dose escalation; optimisation; chemotherapy;
D O I
10.1019/200530078
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction Radiotherapy is involved in several ways in the treatment of non-small cell bronchial carcinoma (NSCBC). Background Three dimensional radiotherapy, with or without chemotherapy, is current practice, radiotherapy with respiratory gating and with intensity modulation are being evaluated Developments in imaging allow more precise definition of target volume, and stereotactic irradiation and proton therapy are little used at present but very promising. Viewpoint The level of local control of NSCBC remains unsatisfactory. The results will certainly improve in association with advances in three areas: chemotherapy, better dose escalation and more precise targeting of tumour volume. Conclusion Improvement in the management of NSCBC depends on these new treatment modalities that are still being evaluated and improved, with the aim of obtaining a longer survival and a better quality of life with reduced toxicity and side effects.
引用
收藏
页码:S124 / S130
页数:7
相关论文
共 50 条
  • [1] CHEMOTHERAPY IN NON-SMALL CELL BRONCHIAL-CARCINOMA
    SOUHAMI, R
    THORAX, 1985, 40 (09) : 641 - 645
  • [2] CHEMOTHERAPY IN NON-SMALL CELL BRONCHIAL-CARCINOMA
    HURT, R
    THORAX, 1986, 41 (04) : 335 - 335
  • [3] Palliative radiotherapy for non-small cell lung carcinoma
    Powell, J.
    Davies, S.
    Lester, J. F.
    Button, M. R.
    Brewster, A. E.
    Hanna, L.
    LUNG CANCER, 2010, 67 : S30 - S30
  • [4] CURATIVE RADIOTHERAPY IN NON-SMALL CELL-CARCINOMA OF THE LUNG
    TALTON, BM
    CONSTABLE, WC
    KERSH, CR
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1990, 19 (01): : 15 - 21
  • [5] Strategies in the adaptation of radiation plans during (chemo-) radiotherapy of advanced non-small cell bronchial carcinoma
    Guckenberger, M.
    Wilbert, J.
    Richter, A.
    Krieger, T.
    Baier, K.
    Kleine, P.
    Flentje, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2009, 185 : 99 - 100
  • [6] WHAT IS CERTAIN IN THE THERAPY OF NON-SMALL CELL BRONCHIAL-CARCINOMA
    GROPP, C
    INTERNIST, 1984, 25 (12): : 747 - 751
  • [7] Generalized rash with osimertinib therapy for non-small cell bronchial carcinoma
    Decroos, Florence
    Grote, Carolin
    Broyer, Jasmin
    Steinkraus, Volker
    HAUTARZT, 2021, 72 (02): : 178 - 180
  • [8] Hypofractionated radiotherapy for oligometastatic non-small cell lung carcinoma.
    Hasselle, M. D.
    Rusthoven, K. E.
    Macrie, B. D.
    Shah, N.
    Golden, D. W.
    Weichselbaum, R. R.
    Salama, J. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [9] The Time factor in postoperative Radiotherapy of non-small cell Lung Carcinoma
    Buetof, R.
    Kirchner, K.
    Appold, S.
    Loeck, S.
    Rolle, A.
    Hoeffken, G.
    Baumann, M.
    Krause, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 : 86 - 86
  • [10] Respiratory motion modelling for optimisation of non-small cell lung cancer (NSCLC) radiotherapy
    Ahmad, S
    Landau, DB
    Blackall, JM
    Miquel, M
    Hawkes, DJ
    BRITISH JOURNAL OF CANCER, 2004, 91 : S15 - S15